Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Association between alcohol consumption and human immunodeficiency virus infection].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2008
Same author

[Lymph node involvement in classic Kaposi sarcoma: report of three cases].

Revista medica de Chile·2007
See all related articles

Related Experiment Video

Updated: Jul 12, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

[Ocular tuberculosis].

M Elena De Benedetti Z1, Bárbara Carranza L, Eduardo Gotuzzo H

  • 1Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|August 31, 2007
PubMed
Summary

Ocular tuberculosis (TB) is an uncommon but significant public health issue. Early recognition and presumptive diagnosis are key for managing this serious eye condition.

Related Experiment Videos

Last Updated: Jul 12, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) poses a global public health challenge, with both pulmonary and extrapulmonary forms.
  • Ocular involvement in TB, though uncommon (up to 1% incidence), requires recognition due to potential severity.
  • Ocular TB can manifest as primary or secondary infections or as a delayed hypersensitivity immune response.

Purpose:

  • To highlight the importance of recognizing ocular tuberculosis (TB).
  • To describe the clinical presentations and diagnostic challenges of ocular TB.
  • To outline the standard treatment protocols for ocular TB.

Summary:

  • Ocular tuberculosis presents with various clinical manifestations, including chronic anterior uveitis, choroiditis, and sclerokeratitis.
  • Diagnosis of ocular TB remains presumptive, relying on clinical findings, systemic assessment, and treatment response, despite advanced molecular techniques.
  • Treatment involves a four-drug regimen for two months, followed by a two-drug regimen for four additional months.

Impact:

  • Improved recognition and diagnosis of ocular TB can lead to timely and effective treatment, potentially preventing vision loss.
  • Understanding the diverse presentations of ocular TB aids clinicians in suspecting and investigating this condition in endemic areas.
  • Standardized treatment protocols contribute to better patient outcomes and management of extrapulmonary tuberculosis.